Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Kangpu Biopharmaceuticals divulges CRBN-binding isoindolines

Aug. 16, 2021

MedImmune patents new ADCs for cancer

Aug. 16, 2021

SSAO inhibitors identified at Shanghai Ennova Biopharmaceutical, Ennovabio Pharmaceuticals

Aug. 13, 2021

Shanghai Hengrui Pharmaceutical and others patent ADCs with eribulin derivatives

Aug. 13, 2021

Shenzhen Salubris Pharmaceuticals presents new cathepsin K inhibitors

Aug. 13, 2021

B-Raf, MEK1 inhibitors discovered at Chugai

Aug. 13, 2021

Nuvation Bio identifies new adenosine A2a receptor antagonists

Aug. 12, 2021

New PTPN11 inhibitors discovered at Betta Pharmaceuticals

Aug. 12, 2021

Jiangsu Hengrui Medicine and collaborators patent antibacterials

Aug. 12, 2021

Janssen describes mutant FimH compositions

Aug. 12, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...